PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy

NCT07443696 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Cardiomyopathy
Heart Failure

Interventions

DRUG: Fasting XTR003/¹⁸F-FDG PET myocardial metabolic imaging
DRUG: Glucose-loaded ¹⁸F-FDG PET Myocardial Metabolic Imaging

Sponsor

Sinotau Pharmaceutical Group